Treatment.com International (TSE:TRUE) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Treatment.com AI has struck a deal to pay an independent consultant in shares for advisory services. The agreement, effective from July 29 to September 10, 2024, will award the consultant with nearly 40,000 shares, valued at $0.77 each, after a four-month holding period. This move showcases the AI healthcare company’s commitment to leveraging its Global Library of Medicine platform to enhance healthcare delivery and education.
For further insights into TSE:TRUE stock, check out TipRanks’ Stock Analysis page.
